J
Jaap van Doesum
Researcher at University Medical Center Groningen
Publications - 28
Citations - 339
Jaap van Doesum is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 5 publications receiving 9 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Livio Pagano,Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Alessandro Busca,Paolo Corradini,Martin Hoenigl,Martin Hoenigl,Nikolai Klimko,Philipp Koehler,Antonio Pagliuca,Francesco Passamonti,Luisa Verga,Benjamin Víšek,Osman Ilhan,Gianpaolo Nadali,Barbora Weinbergerova,Raúl Córdoba-Mascuñano,Monia Marchetti,Graham P. Collins,Francesca Farina,Chiara Cattaneo,Alba Cabirta,Maria Gomes-Silva,Federico Itri,Jaap van Doesum,Marie-Pierre Ledoux,Martin Čerňan,Ozren Jakšić,Rafael F. Duarte,Gabriele Magliano,Ali S. Omrani,Nicola Stefano Fracchiolla,Austin G. Kulasekararaj,Austin G. Kulasekararaj,Toni Valković,Christian Bjørn Poulsen,Marina Machado,Andreas Glenthøj,Igor Stoma,Zdeněk Ráčil,Klára Piukovics,Milan Navrátil,Ziad Emarah,Uluhan Sili,Johan Maertens,Ola Blennow,Rui Bergantim,Carolina García-Vidal,Lucia Prezioso,Anna Guidetti,Maria Ilaria Del Principe,Marina Popova,Nick de Jonge,Irati Ormazabal-Vélez,Noemí Fernández,Iker Falces-Romero,Annarosa Cuccaro,Stef Meers,Caterina Buquicchio,Darko Antic,Murtadha Al-Khabori,Ramón García-Sanz,Monika Biernat,Maria Chiara Tisi,Ertan Sal,Laman Rahimli,Natasa Colovic,Martin Schönlein,Maria Calbacho,Carlo Tascini,Carolina Miranda-Castillo,Nina Khanna,Gustavo-Adolfo Méndez,Verena Petzer,Jan Novák,Caroline Besson,Rémy Duléry,Sylvain Lamure,Marcio Nucci,Giovanni Zambrotta,Pavel Žák,Guldane Cengiz Seval,Valentina Bonuomo,Jiří Mayer,Alberto López-García,Maria Vittoria Sacchi,Stephen Booth,Fabio Ciceri,Margherita Oberti,Marco Salvini,Macarena Izuzquiza,Raquel Nunes-Rodrigues,Emanuele Ammatuna,Aleš Obr,Raoul Herbrecht,Lucía Núñez-Martín-Buitrago,Valentina Mancini,Hawraa M Shwaylia,Mariarita Sciumè,Jenna Essame,Marietta Nygaard,Josip Batinić,Josip Batinić,Yung Gonzaga,Isabel Regalado-Artamendi,Linda Katharina Karlsson,Maryia Shapetska,Michaela Hanakova,Shaimaa El-Ashwah,Zita Borbényi,Gökçe Melis Çolak,Anna Nordlander,Giulia Dragonetti,Giulia Dragonetti,Alessio Maria Edoardo Maraglino,Alessio Maria Edoardo Maraglino,Amelia Rinaldi,Cristina De Ramón-Sánchez,Oliver A Cornely +119 more
TL;DR: In this paper, the authors studied the risk factors for adverse outcomes in patients with hematological malignancies (HM) who developed COVID-19 and analyzed predictors of mortality.
Journal ArticleDOI
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Sabine Haggenburg,Birgit I. Lissenberg-Witte,Rob van Binnendijk,Gerco den Hartog,M. Bhoekhan,Nienke J. E. Haverkate,Dennis M. de Rooij,Johan van Meerloo,Jacqueline Cloos,Neeltje A. Kootstra,Dorine Wouters,Suzanne S Weijers,Ester M. M. van Leeuwen,Hetty J. Bontkes,Saida Tonouh-Aajoud,Mirjam H.M. Heemskerk,Rogier W. Sanders,Elianne A. Roelandse-Koop,Quincy Hofsink,Kaz Groen,Lusia A Çetinel,Louis Schellekens,Yvonne den Hartog,B. Toussaint,Iris M J Kant,Thecla Margaretha Graas/Bouman,Emma de Pater,Willem A. Dik,Marije D Engel,C. Pierie,Susanne R Janssen,Edith van Dijkman,Meliawati Poniman,Judith A. Burger,J. H. Bouhuijs,Gaby Smits,Nynke Y. Rots,Sonja Zweegman,Arnon P. Kater,Tom van Meerten,Pim G N J Mutsaers,Jaap van Doesum,Annoek E.C. Broers,Marit J. van Gils,Abraham Goorhuis,Caroline E. Rutten,Mette D. Hazenberg,Inger S. Nijhof +47 more
TL;DR: Hematology patients on chemotherapy, shortly after HCT, or with chronic GvHD should not be precluded from vaccination.
Journal ArticleDOI
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
Sabine Haggenburg,Quincy Hofsink,Birgit I. Lissenberg-Witte,Annoek E.C. Broers,Jaap van Doesum,Rob van Binnendijk,Gerco den Hartog,M. Bhoekhan,Nienke J. E. Haverkate,Judith A. Burger,J. H. Bouhuijs,Gaby Smits,Dorine Wouters,Ester M. M. van Leeuwen,Hetty J. Bontkes,Neeltje A. Kootstra,Sonja Zweegman,Arnon P. Kater,Mirjam H.M. Heemskerk,Kaz Groen,Tom van Meerten,Pim G N J Mutsaers,Tim Beaumont,Marit J. van Gils,Abraham Goorhuis,Caroline E. Rutten,Mette D. Hazenberg,Inger S. Nijhof +27 more
TL;DR: It is found that the primary schedule for immunocompromised patients with hematologic cancers should be supplemented with a delayed third vaccination, and a third vaccination was associated with significantly improved neutralization capacity per antibody.
Journal ArticleDOI
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano,Jon Salmanton-García,Francesco Marchesi,Ola Blennow,Maria Gomes da Silva,Andreas Glenthøj,Jaap van Doesum,Yavuz M. Bilgin,Alberto Lopez-Garcia,F. Itri,R. Nunes Rodrigues,Barbora Weinbergerova,Francesca Farina,Giulia Dragonetti,Caroline Berg Venemyr,Jens Van Praet,Ozren Jakšić,Toni Valković,Iker Falces-Romero,Sonia Martín Pérez,Moraima Jiménez,J. Dávila-Valls,Martin Schonlein,Emanuele Ammatuna,Stef Meers,Mario Delia,Zlate Stojanoski,Anna Nordlander,Tobias Lahmer,László Imre Pinczés,Caterina Buquicchio,Klára Piukovics,Irati Ormazabal-Vélez,Nicola Stefano Fracchiolla,Michail Samarkos,Gustavo-Adolfo Méndez,Jose Angel Hernandez-Rivas,Ildefonso Espigado,Martin Cernan,Verena Petzer,Sylvain Lamure,Roberta Di Blasi,J. Marques de Almeida,Michelina Dargenio,Monika Biernat,Mariarita Sciumè,Cristina de Ramón,N. D. de Jonge,Josip Batinic,Avinash Aujayeb,Monia Marchetti,Guillemette Fouquet,Noemi Fernandez Escalada,Giovanni Zambrotta,M. Sacchi,Anna Guidetti,Fatih Demirken,Lucia Prezioso,Zdenek Racil,Marcio Nucci,Miloš Mladenović,Raphael Liévin,Michaela Hanakova,S. Grafe,Uluhan Sili,Marina Machado,Chiara Cattaneo,Tatjana Adzic-Vukicevic,Luisa Verga,Jorge Labrador,Laman Rahimli,Matteo Bonanni,Francesco Passamonti,Antonio Pagliuca,Paolo Corradini,Martin Hoenigl,Philipp Koehler,Alessandro Busca,Oliver A. Cornely +78 more
TL;DR: While mortality is significantly lower than in the pre-vaccination era, breakthrough COVID-19 in HM is still associated with considerable mortality.
Journal ArticleDOI
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Ola Blennow,Jon Salmanton-García,Piotr Nowak,F. Itri,Jaap van Doesum,Alberto Lopez-Garcia,Francesca Farina,Ozren Jakšić,László Imre Princzés,Yavuz M. Bilgin,Iker Falces-Romero,Moraima Jiménez,Irati Ormazabal-Vélez,Barbora Weinbergerova,Remy Dulery,Zlate Stojanoski,Tobias Lahmer,Noemí Fernández,Jose Angel Hernandez-Rivas,Verena Petzer,N. D. de Jonge,Andreas Glenthøj,Cristina de Ramón,Monika Biernat,Nicola Stefano Fracchiolla,Avinash Aujayeb,Jens Van Praet,Martin Schönlein,Gustavo-Adolfo Méndez,Chiara Cattaneo,Anna Guidetti,Mariarita Sciumè,Emanuele Ammatuna,Raul Cordoba,Nicole Garcia-Pouton,Stefanie Katharina Gräfe,Alba Cabirta,Dominik Wolf,Anna Nordlander,Ramón García-Sanz,Mario Delia,Caroline Berg Venemyr,C Brones,Roberta Di Blasi,Elizabeth de Kort,Stef Meers,Sylvain Lamure,L. Serrano,Maria Merelli,Nicola Coppola,Rui Bergantim,Caroline Besson,Milena Kohn,Jessica Petiti,Carolina Garcia-Vidal,Michelina Dargenio,François Danion,Marina Machado,Rebeca Bailén-Almorox,Martin Hoenigl,Giulia Dragonetti,Louis Yi Ann Chai,Chi Shan Bonnie Kho,Matteo Bonanni,Raphael Liévin,Francesco Marchesi,Oliver A. Cornely,Livio Pagano +67 more
TL;DR: Risk factors, antiviral treatment and outcomes of SARS-CoV-2 omicron variant infection in 593 HM patients included in the EPICOVIDEHA registry are described.